3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
12
Prostatic Neoplasms
4
Kidney Neoplasms
4
Neoplasms
3
Carcinoma, Hepatocellular
3
Sarcoma, Ewing
2
Osteosarcoma
2
Neuroendocrine Tumors
2
Neoplasm Metastasis
2
Melanoma
2
Lung Neoplasms
2
Clear-cell metastatic renal cell carcinoma
2
Carcinoma, Transitional Cell
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Medullary
2
Carcinoma
2
Adrenocortical Carcinoma
2
von Hippel-Lindau Disease
1
Wilms Tumor
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Urachal adenocarcinoma
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sarcoma, Kaposi
1
Sarcoma, Clear Cell
1
Interventions
pembrolizumab
1
fludarabine phosphate
1
fludarabine
1
decitabine and cedazuridine drug combination
1
avelumab
1
aldesleukin
1
Nivolumab
1
Cyclophosphamide
1
Axitinib
1
Antineoplastic Protocols
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Merkel Cell
×
cabozantinib
×
30 days
×
Clear all
No trials found.